T2GO clinical research study

T2GO is a clinical research study that might interest some of the younger people you know who have Type 2 Diabetes, or their parents.
Dapagliflozin – the study medication that will be used in T2GO – is approved for use in adults with Type 2 Diabetes in approximately 70 countries including the USA and across the EU.

Referral fact sheet

Advocacy Letter


For further information please find contact details in the above attachments